The main result of this study is the absence of prognostic value of pN0(i+) or pN1mi in HER2-positive BC in the whole cohort, but a negative impact on RFS in pT1a-b patients, particularly for those with pT1b tumors. The gene discussed is ERBB2; the disease is breast cancer.